Insider · CIK 0001600049

Bridger Gary

Reports to the SEC for 4 companies · BOSTON, MA

sec.gov

Transactions

Companies

Filings

CIK

0001600049

Forms 4 and 5

Insider transactions

45 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-01	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+110K sh	—	—	0
2025-06-09	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+1,500 sh	—	—	4,722
2024-06-10	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+45K sh	—	—	96,667
2023-06-13	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+45K sh	—	—	51,667
2022-06-06	XFORX4 Pharmaceuticals, IncA Award	Director	AAward	+6,667 sh	—	—	6,667
2021-06-02	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+6,000 sh	$9.50	+$57K	6,000
2020-10-05	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+30K sh	—	—	30,000
2020-06-10	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+3,427 sh	—	—	3,427
2019-03-13	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+21.6K sh	—	—	21,570
2019-03-13	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+21.6K sh	—	—	21,570
2019-03-13	XFORX4 Pharmaceuticals, Inc · Stock Option (right to buy)A Award	Director	AAward	+6,854 sh	—	—	6,854
2018-05-07	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+15K sh	—	—	15,000
2017-05-08	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+9,000 sh	—	—	9,000
2016-05-09	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+7,500 sh	—	—	7,500
2015-10-31	NGNENeurogene Inc.J Other	Director	JOther	−1.54M sh	—	—	0
2015-10-31	ALDER BIOPHARMACEUTICALS INCJ Other	Director	JOther	−3.47M sh	—	—	0
2015-05-19	ALDER BIOPHARMACEUTICALS INCStock Option (Right to Buy)A Award	Director	AAward	+6,350 sh	—	—	6,350
2015-03-12	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+5,000 sh	—	—	5,000
2014-11-21	XENEXenon Pharmaceuticals Inc. · Stock Option (Right to Buy)A Award	EVP, Research & Development	AAward	+5,144 sh	—	—	5,144
2014-03-12	NGNENeurogene Inc.A Award	Director	AAward	+36.5K sh	—	—	40,147
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−40.1K sh	—	—	0
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−284K sh	—	—	0
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−189K sh	—	—	0
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−327K sh	—	—	0
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−325K sh	—	—	0
2014-03-12	NGNENeurogene Inc.D Disposition to Issuer	Director	DDisposition to Issuer	−379K sh	—	—	0
2014-03-12	NGNENeurogene Inc.C Conversion	Director	CConversion	+1.54M sh	—	—	1,543,989
2014-03-12	NGNENeurogene Inc. · Common Exchangeable SharesA Award	Director	AAward	+36.5K sh	$11.00	+$402K	40,147
2014-03-12	NGNENeurogene Inc. · Common Exchangeable SharesC Conversion	Director	CConversion	−40.1K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-1 Exchangeable SharesC Conversion	Director	CConversion	−284K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-1 Preferred StockC Conversion	Director	CConversion	+284K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-1 Preferred StockC Conversion	Director	CConversion	−284K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-2 Exchangeable SharesC Conversion	Director	CConversion	−189K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-2 Preferred StockC Conversion	Director	CConversion	+189K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series A-2 Preferred StockC Conversion	Director	CConversion	−189K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-1 Exchangeable SharesC Conversion	Director	CConversion	−327K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-1 Preferred StockC Conversion	Director	CConversion	+327K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-1 Preferred StockC Conversion	Director	CConversion	−327K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-2 Exchangeable SharesC Conversion	Director	CConversion	−325K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-2 Preferred StockC Conversion	Director	CConversion	+325K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series B-2 Preferred StockC Conversion	Director	CConversion	−325K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series C Exchangeable SharesC Conversion	Director	CConversion	−379K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series C Preferred StockC Conversion	Director	CConversion	+379K sh	—	—	0
2014-03-12	NGNENeurogene Inc. · Series C Preferred StockC Conversion	Director	CConversion	−379K sh	—	—	0
2014-03-06	NGNENeurogene Inc. · Stock Option (Right to Buy)A Award	Director	AAward	+8,333 sh	—	—	8,333

Recent filings

Accepted (ET)
Jan 74
Bridger Gary0001501697-26-000009
SEC(opens sec.gov)
Jun 104
Bridger Gary0001628280-25-030502
SEC(opens sec.gov)
Jun 114
Bridger Gary0001628280-24-027674
SEC(opens sec.gov)
Jun 144
Bridger Gary0001628280-23-022096
SEC(opens sec.gov)
Jun 274
Bridger Gary0001628280-22-018055
SEC(opens sec.gov)
Jun 24
Bridger Gary0001628280-21-011547
SEC(opens sec.gov)
Oct 64
Bridger Gary0001628280-20-014320
SEC(opens sec.gov)
Jun 114
Bridger Gary0001628280-20-009230
SEC(opens sec.gov)
Apr 24/A
Bridger Gary0000899243-19-009671
SEC(opens sec.gov)
Mar 144
Bridger Gary0000899243-19-007832
SEC(opens sec.gov)
May 94
Bridger Gary0001209191-18-028979
SEC(opens sec.gov)
May 104
AQUINOX PHARMACEUTICALS, INC0001209191-17-031395
SEC(opens sec.gov)
May 114
AQUINOX PHARMACEUTICALS, INC0001209191-16-119223
SEC(opens sec.gov)
Nov 34
ALDER BIOPHARMACEUTICALS INC0001209191-15-078174
SEC(opens sec.gov)
Nov 34
AQUINOX PHARMACEUTICALS, INC0001209191-15-078170
SEC(opens sec.gov)
May 214
ALDER BIOPHARMACEUTICALS INC0001209191-15-045526
SEC(opens sec.gov)
Mar 164
AQUINOX PHARMACEUTICALS, INC0001209191-15-026512
SEC(opens sec.gov)
Nov 254
Xenon Pharmaceuticals Inc.0001171843-14-005697
SEC(opens sec.gov)
Mar 144
AQUINOX PHARMACEUTICALS, INC0001209191-14-020603
SEC(opens sec.gov)

Companies

Address

C/O X4 PHARMACEUTICALS, INC. 61 NORTH BEACON STREET, 4TH FLOOR

BOSTON, MA, 02134